Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients

NCT ID: NCT05988125

Last Updated: 2024-10-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients with endovascular therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients is an academic,independent, pragmatic , prospective, multicenter, observational registry study. The acute ischemic stroke patients undergone endovascular therapy will be enrolled in stroke centers. Baseline information and clinical follow-up information at 90 days of stroke onset are collected. Data collected include demographics, comorbidities, pathogenesis, blood pressures, stroke severity on admission, time intervals, reperfusion condition, and functional outcome, et al. The study aims to investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients with endovascular therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endovascular Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Acute ischemic stroke;
2. Brain imaging confirmed intracranial large vessel occlusion: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA V4), and posterior cerebral artery (PCA P1);
3. Initiation of any type of endovascular treatment, including mechanical thrombectomy, aspiration, angioplasty, and stenting;
4. Informed Consent as documented by signature or fulfilling the criteria for emergency consent/ deferral consent

Exclusion Criteria

1. Acute intracranial haemorrhage
2. No evidence of large vessel occlusion on digital subtraction angiography.
3. Patient bedridden or presenting from a nursing home
4. Foreseeable difficulties in follow-up due to geographic reasons (e.g. patients living abroad) -
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fujian Medical University Union Hospital

OTHER

Sponsor Role collaborator

The First Affiliated Hospital of Nanchang University

OTHER

Sponsor Role collaborator

First People's Hospital of Shenyang

OTHER

Sponsor Role collaborator

Tingyu-Yi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tingyu-Yi

Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients in China

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wen-huo Chen, bachelor

Role: PRINCIPAL_INVESTIGATOR

Zhangzhou Affiliated Hospital to Fujian Medical University , Fujian ,China

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhangzhou Municipal Hospital

Zhangzhou, Fujian, China

Site Status RECRUITING

Gansu provincial hospital of TCM

Lanzhou, Gansu, China

Site Status RECRUITING

Jiamusi Central Hospital

Jiamusi, Heilongjiang, China

Site Status RECRUITING

Department of Neurology, The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Site Status RECRUITING

Songyuan Jilin Oilfield Hospital

Songyuan, Jilin, China

Site Status RECRUITING

Shenyang First People's Hospital

Shenyang, Liaoning, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wen-huo Chen, bachelor

Role: CONTACT

+86-05962082582

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wenhuo Chen, MD

Role: primary

13806906089

Hua Cao

Role: primary

18919810265

Lihua Xu, MD

Role: primary

13846178333

xiao-bing Li, M.D.

Role: primary

13970935284

Dong-sheng Ju, MD

Role: primary

13894158599

Yi Sui, MD

Role: primary

13998352587

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ETERNITY

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.